These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32469227)

  • 1. Contribution of selected vasoactive systems to blood pressure regulation in two models of chronic kidney disease.
    Drábková N; Hojná S; Zicha J; Vaněčková I
    Physiol Res; 2020 Jul; 69(3):405-414. PubMed ID: 32469227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exaggerated blood pressure response to fasudil or nifedipine in hypertensive Ren-2 transgenic rats: role of altered baroreflex.
    Vaněčková I; Behuliak M; Hojná S; Kopkan L; Kadlecová M; Zicha J
    Hypertens Res; 2019 Feb; 42(2):145-154. PubMed ID: 30518983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin II in chronic blood pressure control of heterozygous Ren-2 transgenic rats: Peripheral vasoconstriction versus central sympathoexcitation.
    Řezáčová L; Hojná S; Kopkan L; Rauchová H; Kadlecová M; Zicha J; Vaněčková I
    Biomed Pharmacother; 2019 Aug; 116():108996. PubMed ID: 31132670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z; Kramer HJ; Vanourková Z; Cervenka L
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.
    Husková Z; Kramer HJ; Thumová M; Vanourková Z; Bürgelová M; Teplan V; Malý J; Cervenka L
    Kidney Blood Press Res; 2006; 29(2):74-83. PubMed ID: 16651849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
    Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet.
    Vaněčková I; Dobešová Z; Kuneš J; Vernerová Z; Zicha J
    J Hypertens; 2015 Jan; 33(1):161-9. PubMed ID: 25255392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of repeated delivery of angiotensin II AT(1) receptor antisense on distinct vasoactive systems in Ren-2 transgenic rats: young vs. adult animals.
    Vaněčková I; Dobešová Z; Kuneš J; Zicha J
    Hypertens Res; 2012 Jul; 35(7):761-8. PubMed ID: 22399098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal influences on maintenance and reversal of two-kidney one-clip renal hypertension.
    Nyström HC; Jia J; Johansson M; Lambert G; Bergström G
    Acta Physiol Scand; 2002 Jul; 175(3):245-51. PubMed ID: 12100364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct effects of bosentan on NO-dependent vasodilation and calcium influx in heterozygous Ren-2 transgenic rats on high-salt diet.
    Vaněčková I; Hojná S; Kadlecová M; Kompanowska-Jezierska E; Zicha J
    Physiol Res; 2019 Oct; 68(5):717-725. PubMed ID: 31424254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
    Kujal P; Čertíková Chábová V; Škaroupková P; Husková Z; Vernerová Z; Kramer HJ; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Kitada K; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Červenka L
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):227-37. PubMed ID: 24471737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine-sensitive blood pressure component in hypertensive models characterized by high activity of either sympathetic nervous system or renin-angiotensin system.
    Zicha J; Dobešová Z; Behuliak M; Pintérová M; Kuneš J; Vaněčková I
    Physiol Res; 2014; 63(1):13-26. PubMed ID: 24397813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade.
    Vaněčková I; Řezáčová L; Kuneš J; Zicha J
    Life Sci; 2016 Aug; 159():127-134. PubMed ID: 26775568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
    Kopkan L; Kramer HJ; Husková Z; Vanourková Z; Bäcker A; Bader M; Ganten D; Cervenka L
    J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
    Opocenský M; Dvorák P; Malý J; Kramer HJ; Bäcker A; Kopkan L; Vernerová Z; Tesar V; Zima T; Bader M; Ganten D; Janda J; Vanecková I
    Physiol Res; 2004; 53(6):581-93. PubMed ID: 15588125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.
    Čertíková Chábová V; Kujal P; Škaroupková P; Varňourková Z; Vacková Š; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Baranowska I; Hwang SH; Hammock BD; Imig JD; Tesař V; Červenka L
    Kidney Blood Press Res; 2018; 43(2):329-349. PubMed ID: 29529602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of sympathoexcitation during the development of hypertension in Cyp1a1 Ren-2 transgenic rats.
    Zicha J; Hojná S; Kopkan L; Červenka L; Vaněčková I
    Physiol Res; 2019 Apr; 68(2):329-334. PubMed ID: 31037948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.